Endoscopic Recurrence in Crohn’s Disease Patients With Long-Term Ileostomy
Inflammatory Bowel Diseases · 2025
DOI: 10.1093/ibd/izaf153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2025. Verfasst von Lotte Oldenburg und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Amsterdam UMC, Location VUmc, Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The N…. Hauptthemen laut MEDLINE: Crohn Disease, Ileostomy, Ileum, Endoscopy, Gastrointestinal. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
A small but significant proportion of patients with Crohn’s disease (CD) will ultimately require a permanent ileostomy. So far, research has focused primarily on clinical and surgical recurrence rates in the ileum, leaving endoscopic recurrence largely unexplored. The aim of this study was to explore the endoscopic ileal recurrence rate in patients with a long-term ileostomy and to identify potential risk factors.
Methods
We performed a retrospective study of adult CD patients with a long-term ileostomy (≥12 months) at a tertiary referral center.
Results
Through an electronic health record database search, we were able to identify 150 patients. One hundred sixteen patients (77.3%) underwent at least one endoscopic examination of the ileum. Ileal recurrence was detected in 46/116 (39.7%). The 1, 3, and 5-year endoscopic recurrence rates were 11.2%, 27.3%, and 33.0%, respectively. Patients with earlier ileal involvement (hazard ratio [HR] 1.99, 95% confidence interval [CI] 1.09-3.62; P = .02) or previous biological therapy (HR 2.48, 95% CI 1.25-4.89; P = .01) were at higher risk. Fecal calprotectin in ileostomy effluent accurately predicted endoscopic inflammation at a cutoff of 170 mcg/g (sensitivity 77.8%, specificity 94.7%, accuracy 89.9%).
Conclusions
In this retrospective study, 77.3% of ileostomy patients underwent endoscopic assessment during follow-up. Ileal recurrence was detected in 39.7% of patients who underwent endoscopic evaluation. Patients with ileal involvement or preoperative exposure to biologics had the highest risk of recurrence. These patients might benefit from endoscopic monitoring. Fecal calprotectin is a reliable noninvasive marker for detecting ileal inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Amsterdam UMC, Location VUmc, Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands.
- Department of Gastroenterology and Hepatology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel, Brussels, Belgium.
ORCID-Profile: Lotte Oldenburg
Zitieren
APA
Oldenburg, L., Hens, B., Hollenberg, M., & D'Haens, G. (2025). Endoscopic Recurrence in Crohn’s Disease Patients With Long-Term Ileostomy. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izaf153
Vancouver
Oldenburg L, Hens B, Hollenberg M, D'Haens G. Endoscopic Recurrence in Crohn’s Disease Patients With Long-Term Ileostomy. Inflammatory Bowel Diseases. 2025. doi:10.1093/ibd/izaf153
BibTeX
@article{Oldenburg2025,
author = {Oldenburg, Lotte and Hens, Brecht and Hollenberg, Maxime and D'Haens, Geert},
title = {Endoscopic Recurrence in Crohn’s Disease Patients With Long-Term Ileostomy},
journal = {Inflammatory Bowel Diseases},
year = {2025},
doi = {10.1093/ibd/izaf153}
}
EUVIMED